52.80SEK-2.22%Mkt Cap: 72.53M SEKP/E: 0.08Last update: 2026-06-01
Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap72.53M SEK
Enterprise Value72.88M SEK
Revenue (TTM)20.15M SEK
Gross Profit13.13M SEK
Net Income (TTM)-8.33M SEK
Revenue/Share14.67 SEK
Last Price52.80 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0010831321
Valuation
P/E (Trailing)0.08
P/E (Forward)—
PEG—
EV/EBITDA-34.62
EV/Revenue3.62
P/S3.68
P/B6.81
EPS (TTM)678.84
EPS (Forward)—
52W Range
7.45076% of range67.20
52W High67.20 SEK
52W Low7.450 SEK
Profitability
Gross Margin218.79%
Oper. Margin43.41%
EBITDA Margin-10.45%
Profit Margin-138.82%
ROE-76.43%
ROA-45.10%
Growth
Revenue Growth186.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.94M SEK
CapEx (TTM)8.67M SEK
FCF Margin-48.99%
FCF Yield-13.61%
Net Debt-1.30M SEK
Net Debt/EBITDA0.62
Balance Sheet
Debt/Equity—
Current Ratio1.33
Quick Ratio0.72
Book Value/Sh7.935 SEK
Cash/Share0.9440 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:350
Split DateMar 26, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.37M
Float1.23M
Insiders24.73%
Institutions3.50%
Technical
SMA 5020.84 (+153.3%)
SMA 20014.23 (+271.0%)
Beta1.47
S&P 52W Chg27.70%
Avg Vol (30d)29.39K
Avg Vol (10d)43.96K
Technical Indicators
RSI (14)75.5
MACD9.2263
MACD Signal6.7876
MACD Hist.+2.4387
BB Upper57.72 SEK
BB Middle32.37 SEK
BB Lower7.012 SEK
BB Width156.67%
ATR (14)6.908 SEK
Vol Ratio (20d)1.32x